Recently got caught up on Levitee Labs ($LVT.c $LVTTF) newest partnership and it's got me feeling bullish on them.
At the end of December, $LVT announced a strategic partnership with LiveRx Research Group to provide equitable access to Hepatitis C (HCV) Care throughout Alberta, Canada.
LiveRx is dedicated to addressing inequities in the current specialist referral-based HCV care model
In Canada, an estimated 250,000 Canadians are living with chronic HCV and, while treatment for HCV is effective in over 95% of infected patients, it is disproportionately unavailable to certain patient groups across Canada.
Working collaboratively with LiveRx, $LVT will create an easily accessible patient-centric HCV care for underserved patient groups, including those with mental health conditions.
Additionally, $LVT will implement the LifeRx HCV test and treatment program at it's Clinics and pharmacies across Alberta starting in January 2022!
This is a significant partnership as the combination of resources and the implementation of a non-judgmental practice with a community-based approach will make a meaningful impact on healthcare in these communities.
As $LVT was trading in the negative today, it's a great time to stock up.
https://leviteelabs.com/levitee-labs-announces-strategic-partnership-with-liverx-research-group-to-provide-equitable-access-to-hepatitis-c-care-throughout-alberta-canada/